Svar på skriftligt spörsmål om ett effektivare utnyttjande av synonympreparat och biosimilarer

This procedure involves a written response regarding strategies to more effectively utilize generic drugs and biosimilars. The goal is to understand how these more affordable alternatives to original medicines can be better integrated into the healthcare system to optimize resource use. The response affects healthcare providers, pharmaceutical distributors, and the national healthcare budget in Finland. It addresses how medicine substitution policies can be improved to ensure cost-effective access to essential treatments.